CASPIAN-RT Trial: Hypofractionated Consolidative Radiation Therapy After Durvalumab (MEDI4736) Plus Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Latest Information Update: 23 Oct 2023
At a glance
- Drugs Carboplatin (Primary) ; Cisplatin (Primary) ; Durvalumab (Primary) ; Etoposide (Primary)
- Indications Brain metastases; Small cell lung cancer
- Focus Therapeutic Use
- Acronyms CASPIAN-RT
- 16 Oct 2023 Status changed from recruiting to withdrawn prior to enrolment.
- 19 Sep 2023 Planned initiation date (estimated date for recruitment of the first subject) changed from 11 Sep 2023 to 19 Oct 2023.
- 11 Aug 2023 Planned initiation date (estimated date for recruitment of the first subject) changed from 5 Aug 2023 to 11 Sep 2023.